Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+28.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+28.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 146.56% |
| 2024 | -9.11% |
| 2023 | 42.74% |
| 2022 | 69.46% |
| 2021 | 29.99% |
| 2020 | -31.97% |
| 2019 | -60.71% |
| 2018 | -122.91% |
| 2017 | 41.44% |
| 2016 | -121.84% |